| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.6 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.15 | 0.6 |
| mRNA | JQ-1:vorinostat (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.025 | 0.6 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | 0.014 | 0.6 |
| mRNA | palmostatin B | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |